Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Essential thrombocythemia: a hemostatic view of thrombogenic risk factors and prognosis.

Molecular biology reports - 1 Jun 2020

Maleknia Mohsen, Shahrabi Saeid, Ghanavat Majid, Vosoughi Tina, Saki Najmaldin

Abstract excerpt

Essential thrombocythemia (ET) is a classical myeloproliferative neoplasm that is susceptible to hypercoagulable state due to impaired hemostatic system, so that thrombotic complications are the leading cause of mortality in ET patients. The content used in this article has been obtained by the PubMed database and Google Scholar search engine from English-language articles (2000-2019) using the following...

Topics

Join the communities discussing this publication.

Blood Platelets
Endothelial Cells
Hemostasis
Hemostatics
Leukocytes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Platelet Aggregation

Thrombocythemia, Essential

Source

Identifiers

PMID: 32472297
DOI: 10.1007/s11033-020-05536-x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Essential thrombocythemia: a hemostatic view of thrombogenic risk factors and prognosis.PMID 32472297Read ↗

Risk factors for thrombosis and bleeding and their influence on therapeutic decisions in patients with essential thrombocythemia.Semantic proximity Read ↗

[Vascular complications of essential thrombocythemia].Semantic proximity Read ↗

Essential thrombocythemia.Semantic proximity Read ↗

Clinico-hematological profile and thrombotic/hemorrhagic events in 150 chinese patients with essential thrombocythemia.Semantic proximity Read ↗

Predictive factors of thrombosis for patients with essential thrombocythaemia: A single center study.Semantic proximity Read ↗

Prognostic risk model for patients with high-risk polycythemia vera and essential thrombocythemia.Semantic proximity Read ↗

Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management.Semantic proximity Read ↗

Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patients.Semantic proximity Read ↗

It is time to change thrombosis risk assessment for PV and ET?Semantic proximity Read ↗

[Clinical features of essential thrombocythemia and primary myelofibrosis, depending on the molecular characteristics of disease].Semantic proximity Read ↗

Polycythemia vera and essential thrombocythemia: 2015 update on diagnosis, risk-stratification and management.Semantic proximity Read ↗

Extrinsic blood coagulation pathway and risk factors for thrombotic events in patients with essential thrombocythemia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.